Drug intelligence / Profile preview

Smoothol

Development stage
Preclinical
Lead developer
Fontem Ventures
Modality
Small Molecules
Administration
Inhalation
01

Overview

Smoothol is a menthol-flavored electronic cigarette liquid (e-liquid) primarily associated with the **Blu** brand of e-cigarettes, which is owned by **Fontem Ventures** (a subsidiary of **Imperial Brands**). It is a combination product containing **nicotine**, **propylene glycol**, **vegetable glycerin**, and flavoring agents, most notably **menthol**. In scientific literature, particularly in studies investigating the respiratory effects of vaping (e.g., PMID 35611070), Smoothol is frequently utilized as a standardized flavored e-liquid to assess the pulmonary toxicity of e-cigarette aerosols. Research has demonstrated that inhalation of Smoothol aerosol induces oxidative stress, DNA damage, and the release of pro-inflammatory cytokines, such as IL-6 and IL-8, in human lung epithelial cells and fibroblasts. These effects are attributed to both the pharmacological action of nicotine and the specific flavoring chemicals used to achieve its smooth menthol profile. While marketed as a consumer tobacco product, it is often evaluated in clinical and pre-clinical settings for its potential role in smoking cessation and its comparative toxicity to traditional combustible cigarettes.

Brand names
Smoothol
Other names
Blu Smoothol
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on Smoothol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smoothol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call